<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02554097</url>
  </required_header>
  <id_info>
    <org_study_id>CR-SecBS</org_study_id>
    <nct_id>NCT02554097</nct_id>
  </id_info>
  <brief_title>Optimization and Cost-effective Analysis of Secondary Biliary Stones' Managements</brief_title>
  <official_title>Optimization and Cost-effective Analysis of Secondary Biliary Stones' Managements - A Multicenter, Prospective and Retrospective Cohort Study Based on Case Register System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Friendship Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Peking University First Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Xuanwu Hospital, Beijing</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Luhe Hospital, Capital Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Peking University Third Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>China-Japan Friendship Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Tongren Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>LanZhou University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The First Affiliated Hospital of Dalian Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shanghai Zhongshan Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Peking University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Peking Union Medical College Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Beijing Friendship Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with gallstone and confirmed common bile duct stones are registered in this study.
      The three managements for common bile duct stones are endoscopic sphincterotomy (EST),
      laparoscopic common bile duct exploration (LCBDE) and laparoscopic transcystic common bile
      duct exploration (LTCBDE). Patients will be assessed at baseline, preoperative
      investigations, operative method, operative time, conversion to open procedure,
      intraoperative and postoperative complications, and the presence of retained and recurrent
      stones. All patients were followed up for 3 years by telephone interview ang outpatient
      visits. Abdominal US and liver function tests were carried out whenever any abdominal symptom
      appeared during the follow-up period. If there were unusual findings, magnetic resonance
      cholangiopancreatography(MRCP) was carried out.
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>August 2015</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">August 2018</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>3 Years</target_duration>
  <primary_outcome>
    <measure>Rate of Adverse outcomes</measure>
    <time_frame>3 years</time_frame>
    <description>The patients with complication / the total patients</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incremental cost-effectiveness ratio</measure>
    <time_frame>3 years</time_frame>
    <description>the average incremental cost associated with 1 additional unit of the measure of effect</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital stay</measure>
    <time_frame>3 years</time_frame>
    <description>The total days in hospital</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acute cholangitis rate</measure>
    <time_frame>30 days</time_frame>
    <description>The patients with acute cholangitis / the total patients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bile leakage rate</measure>
    <time_frame>30 days</time_frame>
    <description>The patients with bile juice found in the abdominal cavity after procedures / the total patients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stricture of the bile duct rate rate</measure>
    <time_frame>3 years</time_frame>
    <description>The patients with any stricture appeared after the procedures / the total patients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>3 years</time_frame>
    <description>Number of death connected with the procedures and complications / total patients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Perforation Rate</measure>
    <time_frame>30 days</time_frame>
    <description>The patients with perforation after the procedures / the total patients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hemorrhage Rate</measure>
    <time_frame>3 years</time_frame>
    <description>The patients with hemorrhage after the procedures / the total patients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Operation time</measure>
    <time_frame>3 years</time_frame>
    <description>The total time of all the procedures (min)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acute pancreatitis Rate</measure>
    <time_frame>30 days</time_frame>
    <description>The patients with acute pancreatitis after the procedures / the total patients</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">2700</enrollment>
  <condition>Gallstones</condition>
  <condition>Cholelithiasis</condition>
  <condition>Cholecystolithiasis</condition>
  <condition>Choledocholithiasis</condition>
  <arm_group>
    <arm_group_label>EST+LC group</arm_group_label>
    <description>Patients accept the management of endoscopic sphincterotomy and laparoscopic cholecystectomy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LCBDE+LC group</arm_group_label>
    <description>Patients accept the management of laparoscopic common bile duct exploration and laparoscopic cholecystectomy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LTCBDE+LC group</arm_group_label>
    <description>Patients accept the management of laparoscopic transcystic common bile duct exploration and laparoscopic cholecystectomy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>endoscopic sphincterotomy</intervention_name>
    <description>Sphincterotomy (EST) is performed to remove the common bile duct stone.</description>
    <arm_group_label>EST+LC group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>laparoscopic common bile duct exploration</intervention_name>
    <description>Transductal exploration was carried out to remove the common bile duct stone. Primary closure or a T tube drainage was performed according to the results of transductal surgery.</description>
    <arm_group_label>LCBDE+LC group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>laparoscopic transcystic common bile duct exploration</intervention_name>
    <description>A wide local dissection of Calot's triangle is performed and a 2.8mm, 3-mm or 5-mm flexible choledochoscope according to the diameter of the cystic duct is inserted through the cystic duct into the common bile duct. After the common bile duct stone is removed, the cystic duct was ligated with Hem-o-lok.</description>
    <arm_group_label>LTCBDE+LC group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>laparoscopic cholecystectomy</intervention_name>
    <description>Laparoscopic cholecystectomy is performed to remove the gallbladder.</description>
    <arm_group_label>EST+LC group</arm_group_label>
    <arm_group_label>LCBDE+LC group</arm_group_label>
    <arm_group_label>LTCBDE+LC group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients are diagnosed with gallstones and common bile duct stones.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with age between 18 - 80 years.

          -  Patients diagnosed with gallstones.

          -  Patients diagnosed with common bile duct stone by one of the three exam (MRI„ÄÅMRCP and
             CT).

          -  Patients diagnosed with common bile duct stone by intro-operative cholangiography or
             transcystic exploration.

          -  Patients accepted one of the three managements (EST+LC, LCBDE and LTCBDE).

        Exclusion Criteria:

          -  Combined with Mirizzi syndrome and intrahepatic bile duct stones

          -  Previous EST/endoscopic retrograde cholangiopancreatography (ERCP) or percutaneous
             transhepatic biliary drainage (PTBD)

          -  History of upper abdominal surgery.

          -  Serious heart,brain,lung, metabolic diseases history.

          -  Pregnant women

          -  Unwillingness or inability to consent for the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zhongtao Zhang, Doctor</last_name>
    <role>Study Chair</role>
    <affiliation>Beijing Friendship Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Beijing Friendship Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100050</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 15, 2015</study_first_submitted>
  <study_first_submitted_qc>September 17, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 18, 2015</study_first_posted>
  <last_update_submitted>August 17, 2017</last_update_submitted>
  <last_update_submitted_qc>August 17, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 22, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Beijing Friendship Hospital</investigator_affiliation>
    <investigator_full_name>Zhongtao Zhang</investigator_full_name>
    <investigator_title>Doctor</investigator_title>
  </responsible_party>
  <keyword>laparoscopic transcystic common bile duct exploration</keyword>
  <keyword>laparoscopic common bile duct exploration</keyword>
  <keyword>endoscopic sphincterotomy,</keyword>
  <keyword>cost-effective analysis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gallstones</mesh_term>
    <mesh_term>Cholelithiasis</mesh_term>
    <mesh_term>Cholecystolithiasis</mesh_term>
    <mesh_term>Choledocholithiasis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

